Please use this identifier to cite or link to this item:
DC FieldValueLanguage
dc.contributor.authorTapia-Barredo, Leandro-
dc.contributor.authorPeña, Paola-
dc.contributor.authorPaulino-Ramírez, Robert-
dc.identifier.citationJournal of the International AIDS Society, 21 (S3), e25093-
dc.description.abstractBackground: Although the hepatitis B vaccine began widely used in high-income countries in the 1980s, almost 20 years later it was still rarely used in low- and middle-income countries. The main reasons behind these gaps included limited money for immunization, a lack of the infrastructure needed to carry out effective immunization programs, and a lack of political interest in immunization [1]. It is estimated a HBV prevalence of 2 to 4% in the Caribbean, and for HCV it is around 1.2% in the Latin-American region [2]. In the DR prevalence of both HIV and/or HBV/HCV are higher among GMT persons [3]. Materials and methods: Patients enrolled in care in a community-based clinic in Santo Domingo were evaluated for clinical indicators of HBV/HCV/Syphilis and HIV infections. A proposed model of cascade of care was proposed with the indicators found (Figures 1, 2) Results: A total of 2435 cases of HIV (+) patients were evaluated. Serological tests demonstrating HBsAg detection was 91% (n = 2238), and co-infection HIV/HBV was 63% (n = 29), and Tenofovir-based ARV regimens among HBsAg (+) was 49% (n = 14) The mean age in the HIV/HBV/HCV cohort was 44 years old, 71.8% were male, and of those 12% was MSM. HCV/HIV co-infection was 41%(n = 19), and the frequency of HIV/HBV/HCV was only 4.3%. In all cases there were no HBV or HCV viral loads available, and none of them with treatment for HCV infection. Among those with HBV infection and HIV 48% was on ARV Tenofovir-based treatment. Conclusions: This study reveals that it is needed more investment on early detection and intensive screening for both HBV and HCV in the context of non-HIV positive patients. The proposed cascade of care to monitor interventions requires a scale-up in case reporting and early treatment in each scenario.en
dc.subjectCiencias de la Salud-
dc.titleMonitoring hepatitis B and C infections among HIV patients: a proposed model for a cascade of care in viral hepatitis in the Dominican Republic [poster]en
dc.typeConference Poster-
dc.relation.conferenceHIV & Hepatitis in the Americas 19‐21 April 2018, Mexico City, Mexico-
dc.contributor.affiliationInstituto de Medicina Tropical y Salud Global (IMTSAG)-
dc.contributor.affiliationInstituto de Medicina Tropical y Salud Global (IMTSAG)-
dc.contributor.affiliationInstituto de Medicina Tropical y Salud Global (IMTSAG)-
dc.contributor.authorsTapia-Barredo, Leandro-
dc.contributor.authorsPeña, Paola-
dc.contributor.authorsMatos, Y.-
dc.contributor.authorsValerio, K.-
dc.contributor.authorsMuñoz, M.-
dc.contributor.authorsLedesma, J.-
dc.contributor.authorsJiménez, M.-
dc.contributor.authorsPaulino-Ramírez, Robert-
dc.typeofaccessOpen Access-
item.openairetypeConference Poster-
item.fulltextCon texto completo - de Medicina Tropical y Salud Global (IMTSAG)- de Medicina Tropical y Salud Global (IMTSAG)- de Medicina Tropical y Salud Global (IMTSAG)- Iberoamericana (UNIBE)- Iberoamericana (UNIBE)- Iberoamericana (UNIBE)-
Appears in Collections:Publicaciones del IMTSAG-UNIBE
Files in This Item:
File Description SizeFormat
P016.pdfFull text [open access]984.49 kBAdobe PDFView/Open
jia2.25093.pdfFull text [open access] supplement6.62 MBAdobe PDFView/Open
Show simple item record Recommend this item

Google ScholarTM






Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.